Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1996 Jul 1;98(1):185–191. doi: 10.1172/JCI118765

Evidence that the fibrinogen binding domain of Apo(a) is outside the lysine binding site of kringle IV-10: a study involving naturally occurring lysine binding defective lipoprotein(a) phenotypes.

O Klezovitch 1, C Edelstein 1, A M Scanu 1
PMCID: PMC507415  PMID: 8690792

Abstract

It is now established that the lysine binding site (LBS) of apo(a) kringle IV-10, and particularly Trp72, plays a dominant role in the binding of lipoprotein(a) [Lp(a)] to lysine. To determine the role of the LBS in the binding of Lp(a) to fibrinogen, we examined the binding to plasmin-modified (PM) fibrinogen of human and rhesus monkey Lp(a) species classified as either Lys' or Lys- based on their capacity to bind lysine Sepharose and to have Trp or Arg, respectively, in position 72 of the LBS of kringle IV-10. We also examined the free apo(a)s obtained by subjecting their corresponding parent Lp(a)s to a mild reductive procedure developed in our laboratory. Our results show that both Lyst and Lys- Lp(a)s and their derived apo(a)s, bound to PM-fibrinogen with similar affinities (Kds: 33-100 nM), whereas the B(max) values were threefold higher for apo(a)s. Both the lysine analog epsilon-aminocaproic acid and L-proline inhibited the binding of Lp(a) and apo(a) to PM fibrinogen. We conclude that the LBS of kringle IV-10 is not involved in this process and that apo(a) binds to PM-fibrinogen via a lysine-proline-sensitive domain located outside the LBS and largely masked by the interaction of apo(a) with apoB100. The significant difference in the PM fibrinogen binding capacity also suggests that apo(a) may have a comparatively higher athero-thrombogenic potential than parent Lp(a).

Full Text

The Full Text of this article is available as a PDF (194.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong V. W., Walli A. K., Seidel D. Isolation, characterization, and uptake in human fibroblasts of an apo(a)-free lipoprotein obtained on reduction of lipoprotein(a). J Lipid Res. 1985 Nov;26(11):1314–1323. [PubMed] [Google Scholar]
  2. Cushing G. L., Gaubatz J. W., Nava M. L., Burdick B. J., Bocan T. M., Guyton J. R., Weilbaecher D., DeBakey M. E., Lawrie G. M., Morrisett J. D. Quantitation and localization of apolipoproteins [a] and B in coronary artery bypass vein grafts resected at re-operation. Arteriosclerosis. 1989 Sep-Oct;9(5):593–603. doi: 10.1161/01.atv.9.5.593. [DOI] [PubMed] [Google Scholar]
  3. Eaton D. L., Fless G. M., Kohr W. J., McLean J. W., Xu Q. T., Miller C. G., Lawn R. M., Scanu A. M. Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen. Proc Natl Acad Sci U S A. 1987 May;84(10):3224–3228. doi: 10.1073/pnas.84.10.3224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Edelstein C., Mandala M., Pfaffinger D., Scanu A. M. Determinants of lipoprotein(a) assembly: a study of wild-type and mutant apolipoprotein(a) phenotypes isolated from human and rhesus monkey lipoprotein(a) under mild reductive conditions. Biochemistry. 1995 Dec 19;34(50):16483–16492. doi: 10.1021/bi00050a032. [DOI] [PubMed] [Google Scholar]
  5. Ernst A., Helmhold M., Brunner C., Pethö-Schramm A., Armstrong V. W., Müller H. J. Identification of two functionally distinct lysine-binding sites in kringle 37 and in kringles 32-36 of human apolipoprotein(a). J Biol Chem. 1995 Mar 17;270(11):6227–6234. doi: 10.1074/jbc.270.11.6227. [DOI] [PubMed] [Google Scholar]
  6. Fless G. M., Snyder M. L., Furbee J. W., Jr, Garcia-Hedo M. T., Mora R. Subunit composition of lipoprotein(a) protein. Biochemistry. 1994 Nov 15;33(45):13492–13501. doi: 10.1021/bi00249a038. [DOI] [PubMed] [Google Scholar]
  7. Fless G. M., Snyder M. L. Polymorphic forms of Lp(a) with different structural and functional properties: cold-induced self-association and binding to fibrin and lysine-Sepharose. Chem Phys Lipids. 1994 Jan;67-68:69–79. doi: 10.1016/0009-3084(94)90125-2. [DOI] [PubMed] [Google Scholar]
  8. Fless G. M., Snyder M. L., Scanu A. M. Enzyme-linked immunoassay for Lp[a]. J Lipid Res. 1989 May;30(5):651–662. [PubMed] [Google Scholar]
  9. Fleury V., Anglés-Cano E. Characterization of the binding of plasminogen to fibrin surfaces: the role of carboxy-terminal lysines. Biochemistry. 1991 Jul 30;30(30):7630–7638. doi: 10.1021/bi00244a035. [DOI] [PubMed] [Google Scholar]
  10. Frank S., Durovic S., Kostner G. M. Structural requirements of apo-a for the lipoprotein-a assembly. Biochem J. 1994 Nov 15;304(Pt 1):27–30. doi: 10.1042/bj3040027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Harpel P. C., Gordon B. R., Parker T. S. Plasmin catalyzes binding of lipoprotein (a) to immobilized fibrinogen and fibrin. Proc Natl Acad Sci U S A. 1989 May;86(10):3847–3851. doi: 10.1073/pnas.86.10.3847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Harpel P. C., Hermann A., Zhang X., Ostfeld I., Borth W. Lipoprotein(a), plasmin modulation, and atherogenesis. Thromb Haemost. 1995 Jul;74(1):382–386. [PubMed] [Google Scholar]
  13. Hervio L., Chapman M. J., Thillet J., Loyau S., Anglés-Cano E. Does apolipoprotein(a) heterogeneity influence lipoprotein(a) effects on fibrinolysis? Blood. 1993 Jul 15;82(2):392–397. [PubMed] [Google Scholar]
  14. Huby T., Schröder W., Doucet C., Chapman J., Thillet J. Characterization of the N-terminal and C-terminal domains of human apolipoprotein(a): relevance to fibrin binding. Biochemistry. 1995 Jun 6;34(22):7385–7393. doi: 10.1021/bi00022a011. [DOI] [PubMed] [Google Scholar]
  15. Klezovitch O., Scanu A. M. Lys and fibrinogen binding of wild-type (Trp72) and mutant (Arg72) human apo(a) kringle IV-10 expressed in E coli and CHO cells. Arterioscler Thromb Vasc Biol. 1996 Mar;16(3):392–398. doi: 10.1161/01.atv.16.3.392. [DOI] [PubMed] [Google Scholar]
  16. Kluft C., Jie A. F., Los P., de Wit E., Havekes L. Functional analogy between lipoprotein(a) and plasminogen in the binding to the kringle 4 binding protein, tetranectin. Biochem Biophys Res Commun. 1989 Jun 15;161(2):427–433. doi: 10.1016/0006-291x(89)92616-8. [DOI] [PubMed] [Google Scholar]
  17. Lackner C., Boerwinkle E., Leffert C. C., Rahmig T., Hobbs H. H. Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis. J Clin Invest. 1991 Jun;87(6):2153–2161. doi: 10.1172/JCI115248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. LoGrasso P. V., Cornell-Kennon S., Boettcher B. R. Cloning, expression, and characterization of human apolipoprotein(a) kringle IV37. J Biol Chem. 1994 Aug 26;269(34):21820–21827. [PubMed] [Google Scholar]
  19. Lucas M. A., Fretto L. J., McKee P. A. The binding of human plasminogen to fibrin and fibrinogen. J Biol Chem. 1983 Apr 10;258(7):4249–4256. [PubMed] [Google Scholar]
  20. McLean J. W., Tomlinson J. E., Kuang W. J., Eaton D. L., Chen E. Y., Fless G. M., Scanu A. M., Lawn R. M. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature. 1987 Nov 12;330(6144):132–137. doi: 10.1038/330132a0. [DOI] [PubMed] [Google Scholar]
  21. Pepin J. M., O'Neil J. A., Hoff H. F. Quantification of apo[a] and apoB in human atherosclerotic lesions. J Lipid Res. 1991 Feb;32(2):317–327. [PubMed] [Google Scholar]
  22. Rath M., Niendorf A., Reblin T., Dietel M., Krebber H. J., Beisiegel U. Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients. Arteriosclerosis. 1989 Sep-Oct;9(5):579–592. doi: 10.1161/01.atv.9.5.579. [DOI] [PubMed] [Google Scholar]
  23. Rouy D., Koschinsky M. L., Fleury V., Chapman J., Anglés-Cano E. Apolipoprotein(a) and plasminogen interactions with fibrin: a study with recombinant apolipoprotein(a) and isolated plasminogen fragments. Biochemistry. 1992 Jul 14;31(27):6333–6339. doi: 10.1021/bi00142a024. [DOI] [PubMed] [Google Scholar]
  24. Sangrar W., Marcovina S. M., Koschinsky M. L. Expression and characterization of apolipoprotein(a) kringle IV types 1, 2 and 10 in mammalian cells. Protein Eng. 1994 May;7(5):723–731. doi: 10.1093/protein/7.5.723. [DOI] [PubMed] [Google Scholar]
  25. Scanu A. M., Edelstein C. Kringle-dependent structural and functional polymorphism of apolipoprotein (a). Biochim Biophys Acta. 1995 Apr 28;1256(1):1–12. doi: 10.1016/0005-2760(95)00012-2. [DOI] [PubMed] [Google Scholar]
  26. Scanu A. M., Fless G. M. Lipoprotein (a). Heterogeneity and biological relevance. J Clin Invest. 1990 Jun;85(6):1709–1715. doi: 10.1172/JCI114625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Scanu A. M., Miles L. A., Fless G. M., Pfaffinger D., Eisenbart J., Jackson E., Hoover-Plow J. L., Brunck T., Plow E. F. Rhesus monkey lipoprotein(a) binds to lysine Sepharose and U937 monocytoid cells less efficiently than human lipoprotein(a). Evidence for the dominant role of kringle 4(37). J Clin Invest. 1993 Jan;91(1):283–291. doi: 10.1172/JCI116182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Scanu A. M., Pfaffinger D., Lee J. C., Hinman J. A single point mutation (Trp72-->Arg) in human apo(a) kringle 4-37 associated with a lysine binding defect in Lp(a). Biochim Biophys Acta. 1994 Oct 21;1227(1-2):41–45. doi: 10.1016/0925-4439(94)90104-x. [DOI] [PubMed] [Google Scholar]
  29. Smith E. B., Cochran S. Factors influencing the accumulation in fibrous plaques of lipid derived from low density lipoprotein. II. Preferential immobilization of lipoprotein (a) (Lp(a)). Atherosclerosis. 1990 Oct;84(2-3):173–181. doi: 10.1016/0021-9150(90)90088-z. [DOI] [PubMed] [Google Scholar]
  30. Tomlinson J. E., McLean J. W., Lawn R. M. Rhesus monkey apolipoprotein(a). Sequence, evolution, and sites of synthesis. J Biol Chem. 1989 Apr 5;264(10):5957–5965. [PubMed] [Google Scholar]
  31. Trieu V. N., Zioncheck T. F., Lawn R. M., McConathy W. J. Interaction of apolipoprotein(a) with apolipoprotein B-containing lipoproteins. J Biol Chem. 1991 Mar 25;266(9):5480–5485. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES